Old Web
English
Sign In
Acemap
>
authorDetail
>
E. Nueesch
E. Nueesch
Hoffmann-La Roche
Medicine
Pathology
Immunohistochemistry
treatment response
Biomarker (medicine)
2
Papers
4
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
BET INHIBITOR RG6146, VENETOCLAX, AND RITUXIMAB IS A HIGHLY ACTIVE REGIMEN IN RELAPSED/REFRACTORY (R/R) DLBCL: INITIAL REPORT OF PHASE 1B SAFETY, BIOMARKER, AND RESPONSE DATA
2019
Hematological Oncology
Michael Dickinson
J. Briones Mejjide
Alex F. Herrera
E. González Barca
Nilanjan Ghosh
Raúl Córdoba
Sarah C. Rutherford
Ranjana H. Advani
E. Bournazou
E. Labriola‐Tompkins
T. Friess
E. Chesné
J. Brouwer‐Visser
Katharina Lechner
B. Brennan
E. Nueesch
M. De Mario
Martin Hutchings
Show All
Source
Cite
Save
Citations (1)
JCES 01.27 Patients with ALK IHC-Positive/FISH-Negative NSCLC Benefit from ALK TKI Treatment: Response Data from the Global ALEX Trial
2017
Journal of Thoracic Oncology
T. Mok
Solange Peters
D. Ross Camidge
Shirish M. Gadgeel
S-H.I. Ou
D. Kim
Rafal Dziadziuszko
F. De Marinis
Randeep Sangha
Ali Zeaiter
Johannes Noe
E. Nueesch
Ting Liu
Isabell Loftin
C. Williams
Alice T. Shaw
Show All
Source
Cite
Save
Citations (3)
1